FIC
UTHR icon

FCG Investment Company’s United Therapeutics UTHR Stock Holding History

FCG Investment Company’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.36M Buy
+2,506
New +$1.41M 0.47% 63
2025
Q2 		– Sell
-5,026
Closed -$1.55M – 116
2025
Q1 		$1.55M Sell
5,026
-14
-0.3% -$4.8K 0.97% 32
2024
Q4 		$1.78M Buy
5,040
+472
+10% +$173K 1.08% 26
2024
Q3 		$1.64M Buy
+4,568
New +$1.54M 1.07% 29

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

FCG Investment Company's UTHR Position: Q2 2026 in Review

FCG Investment Company opened a new position in United Therapeutics (UTHR) in Q2 2026: 2,506 shares worth $1.36M. The stake represents 0.47% of the portfolio and ranks #63 among its holdings. This is a return to the name: FCG Investment Company previously reported a position in UTHR as recently as Q1 2025.

FCG Investment Company first reported a position in UTHR in Q3 2024 and has held it in 4 quarters since. The position peaked at $1.78M in Q4 2024. 881 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • FCG Investment Company held 2,506 shares of United Therapeutics worth $1.36M as of Q2 2026.
  • United Therapeutics was a new FCG Investment Company position in Q2 2026.
  • United Therapeutics made up 0.47% of FCG Investment Company's portfolio in Q2 2026, its #63 holding.
  • FCG Investment Company first reported a position in United Therapeutics in Q3 2024 and has held it in 4 quarters since.
  • FCG Investment Company's United Therapeutics position peaked at $1.78M in Q4 2024.
  • 881 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on FCG Investment Company's 13F filing for Q2 2026, filed 13 Jul 2026.